Hypersensitivity reaction to Hyaluronic Acid Dermal filler following novel Coronavirus infection - a case report.
J Cosmet Dermatol
; 20(5): 1557-1562, 2021 May.
Article
in English
| MEDLINE | ID: covidwho-1140266
ABSTRACT
The incidence of hypersensitivity reactions to hyaluronic acid dermal fillers is between 0.3 and 4.25%, mediated by T-lymphocytes. Flu-like illness can trigger immunogenic reactions at the site of filler placement. Cases of SARS-CoV-2 are significant and pose a possible risk of inducing hypersensitivity. This case report is of a delayed-type hypersensitivity after hyaluronic acid dermal filler treatment of the nose and subsequent infection with SARS-CoV-2. Risk factors for the development of such symptoms were identified as the presence of hyaluronic acid combined with flu-like illness and repeated treatment of one area. The case resolved without intervention. Clinicians should be mindful of the risk posed by the interaction of hyaluronic acid dermal filler with SARS-CoV-2 in light of the pandemic.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Dermal Fillers
/
COVID-19
/
Hyaluronic Acid
/
Hypersensitivity
Type of study:
Case report
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
J Cosmet Dermatol
Journal subject:
Dermatology
Year:
2021
Document Type:
Article
Affiliation country:
Jocd.14074
Similar
MEDLINE
...
LILACS
LIS